
不建议进入,这个市场已经偏红海,且对新品牌和小商家都不友好。 关键不是“有没有需求”,而是现在的利润结构和新入场成功率都在恶化:新释放产品可盈利率只有20.00%,新品牌里可见成功率只有10.00%,而近一年新上架35个里只有很少数能稳定赚钱,已经不是适合试错的阶段。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很明确:不建议进入,这个市场偏饱和且新入局成功率低。 用户预算 50万人民币(约7万美金)只能覆盖少数新ASIN的前期投入,但市场里新品牌新上架产品的盈利率只有10%,新上架整体盈利率也只有20%,而且最近几个月持续出现更多非盈利新品,说明竞争在加剧而不是放缓。
Alternative solutions may pose a risk to your investment in certain markets.
结论很明确:这个市场不值得进入,已经接近价格战区,且对新品牌不友好。 目前样本里整体可盈利产品只有30.43%,新上架产品可盈利率只有20.00%;更关键的是,新品牌新上架产品的失败率高达80.00%,这不是一个适合贸然入场的市场。
这个市场不值得进入,结论很明确:已经偏向红海,而且对新品牌和小商家都不友好。 新品里只有20.00%盈利,20%以下的新发布利润率大量集中在0~10%,再加上近一年新品发布明显在增多、但亏损新品占比更高,说明市场正在往更激烈的价格战走;尤其像 Vaseline、Her Fantasy Box 这类老品牌/强品牌在新款上还能跑出来,但这不是小商家的成功模板,而是品牌力和持续投放换来的结果。
**证据很硬:市场利润结构中,0~10%只占17.14%,但“其他/未充分验证”占40.00%,可见真正能稳定赚钱的新品不多;已识别的盈利新品里,Vaseline 的 B0GT1NZX5Y 18.34%利润率、B0FWKTPL7Z 14.17%、B0GT1TRLQ3 13.07%,Her Fantasy Box 的 B0G3ZX7RGW 21.07%、B0G3ZQC5XX 21.08%,Omexry 的 B0GQBJSS1X 18.34%。但这背后的门槛很高:Vaseline 新品 B0GT1NZX5Y 近月卖 4000 件、月营收 $64,880,B0FWKTPL7Z 5000 件、$68,300;Her Fantasy Box 的 B0G3ZX7RGW 月营收 $47,940。反过来,Omexry 作为新品牌,B0GQBJSS1X 只有 46 个评论、近月只卖 50 件、月营收 $650.50,早期总投入却高达 $30,237.32,说明新品牌要靠很重的投放和运气才能活下来。更关键的是,Omexry 另一款 B0FKXWCDGD 只有 2.96% 利润率,说明新品牌自己也在踩价格战坑。另一个明显信号是伪成长风险:B0G3ZQC5XX 2,199 评论、B0GT1TRLQ3 355 评论、B0GT1NZX5Y 355 评论,这种评论速度对“白手起家小商家”不现实,明显更像强营销或老品牌资源堆出来的结果。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B004AI97MA | Bio-Oil | 2011-04-10 | Yes | $20.93 | 20000pcs | $418600.0 | 33.19% | $138933.34 |
![]() | B000VPPUEA | Bio-Oil | 2015-06-10 | Yes | $10.83 | 20000pcs | $216600.0 | 17.59% | $38099.94 |
![]() | B0FB9LRL1V | Palmer's | 2025-05-29 | Yes | $15.14 | 10000pcs | $151400.0 | 21.69% | $32838.66 |
![]() | B08D43LHYP | Aveeno | 2020-07-02 | Yes | $9.53 | 20000pcs | $190600.0 | 12.57% | $23958.42 |
![]() | B01B12KCGC | Ancient Greek Remedy | 2016-01-26 | Yes | $15.23 | 6000pcs | $91380.0 | 24.95% | $22799.31 |
![]() | B0D1QYBNNQ | Yoken | 2024-06-30 | Yes | $15.67 | 6000pcs | $94020.0 | 21.06% | $19800.62 |
![]() | B0FB9LWGY5 | Palmer's | 2025-05-29 | Yes | $13.6 | 8000pcs | $108800.0 | 16.28% | $17712.64 |
![]() | B0GT1NZX5Y | Vaseline | 2026-03-18 | Yes | $16.22 | 4000pcs | $64880.0 | 27.23% | $17666.83 |
![]() | B001B0ZZFS | Neutrogena | 2011-05-05 | Yes | $14.23 | 5000pcs | $71150.0 | 18.48% | $13148.52 |
![]() | B0DMD7K2JS | Her Fantasy Box | 2024-11-08 | Yes | $15.95 | 3000pcs | $47850.0 | 21.18% | $10134.63 |
![]() | B0G3ZX7RGW | Her Fantasy Box | 2025-11-26 | Yes | $15.98 | 3000pcs | $47940.0 | 21.07% | $10100.96 |
![]() | B0FWKTPL7Z | Vaseline | 2026-01-19 | Yes | $13.66 | 5000pcs | $68300.0 | 14.17% | $9678.11 |
![]() | B0D8QLGD8Q | Palmer's | 2024-07-03 | Yes | $12.52 | 4000pcs | $50080.0 | 17.21% | $8618.77 |
![]() | B089NCFBQZ | Vaseline | 2020-08-07 | Yes | $10.22 | 6000pcs | $61320.0 | 13.83% | $8480.56 |
![]() | B0GT1TRLQ3 | Vaseline | 2026-03-18 | Yes | $11.18 | 4000pcs | $44720.0 | 13.07% | $5844.91 |
![]() | B001KYU1H2 | Palmer's | 2011-04-09 | Yes | $10.98 | 3000pcs | $32940.0 | 14.39% | $4740.07 |
![]() | B0F5X6K8J7 | Soothing House | 2025-04-22 | Yes | $18.99 | 900pcs | $17091.0 | 25.26% | $4317.19 |
![]() | B0F5X5Y2ZR | Soothing House | 2025-04-22 | Yes | $19.37 | 700pcs | $13559.0 | 25.92% | $3514.5 |
![]() | B01N17AUG7 | Advanced Clinicals | 2017-02-01 | Yes | $15.05 | 900pcs | $13545.0 | 24.96% | $3380.84 |
![]() | B0F5X66JJR | Soothing House | 2025-04-22 | Yes | $18.99 | 700pcs | $13293.0 | 25.42% | $3379.09 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0GT1NZX5Y | Vaseline | 2026-03-18 | Yes | $16.22 | 4000pcs | $64880.0 | 27.23% | $17666.83 |
![]() | B0G3ZX7RGW | Her Fantasy Box | 2025-11-26 | Yes | $15.98 | 3000pcs | $47940.0 | 21.07% | $10100.96 |
![]() | B0FWKTPL7Z | Vaseline | 2026-01-19 | Yes | $13.66 | 5000pcs | $68300.0 | 14.17% | $9678.11 |
![]() | B0GT1TRLQ3 | Vaseline | 2026-03-18 | Yes | $11.18 | 4000pcs | $44720.0 | 13.07% | $5844.91 |
![]() | B0G3ZQC5XX | Her Fantasy Box | 2025-11-26 | Yes | $15.98 | 800pcs | $12784.0 | 21.08% | $2694.87 |
![]() | B0G3ZYFPFY | Her Fantasy Box | 2025-11-26 | Yes | $15.98 | 600pcs | $9588.0 | 21.08% | $2021.16 |
![]() | B0GQBJSS1X | Omexry | 2026-02-26 | Yes | $13.01 | 50pcs | $650.5 | 18.34% | $119.31 |
这个市场不适合现在进入,已经接近价格战区,而且对新品牌极不友好。 新产品整体盈利率只有30.43%,但新上新产品里真正盈利的只有20.00%,而新品牌自己上新的盈利率更低,只有11.11%,失败率高达88.89%;这说明不是“还有机会”,而是大多数新玩家都在亏。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
结论很明确:这个市场不适合进入,已经偏向价格战和过度拥挤。 近一年新增品牌只有5个,但新增上架35个里只有20%是成功的,最新阶段新产品利润率只在3.96%~19.44%,说明不是“好做”,而是“能活下来就不错”。
证据很硬:2025年新发布9个里只有1个赚钱,失败率88.89%;2026年新发布21个里也只有4个可见盈利,最近月份更是连续出现大量非盈利新品。 近一年真正成功的新品牌几乎只剩 Omexry 的 1 个成功案例;失败则集中在 Omexry、Krajiyya、Apricot20、Apothecary Basics 等新品牌身上,说明新入场者普遍打不过现有竞争。市场投资门槛表面上不高,单个新ASIN建议预算约1050.91~13229.34美元,但这只是前期货源/物流/营销,不含研发、品牌和认证;对你500000元人民币预算来说资金够用,但不代表值得做,因为回报结构太差。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 1 | 2 | 0 | 3 | 0 | 0 | 8 |
| 2026 | 0 | 0 | 4 | 3 | 1 | 0 | 0 | 13 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/8 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 5 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 1 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3 |
| 2026/3 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 2 |
| 2026/4 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2026/6 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |